Den mest almindelige infektionstype hos tigecyklin- behandlede patienter i kliniske forsøg med komplicerede hud - og bløddelsinfektioner var cellulitis (59%), efterfulgt af svære abscesser (27, 5%).
In clinical trials in complicated skin and soft tissue infections, the most common type of infection in tigecycline treated-patients was cellulitis (59%), followed by major abscesses (27.5%).